À proposConditionsConfidentialitéContact
 
Actualisation
Business Of Biotech

Business Of Biotech

Matt Pillar
Date de sortie : 2022-03-14
© 2022 Business Of Biotech
Business Of Biotech - QR Code
LibreNew
88 épisodes
Audio
Écouter sur Apple Podcasts
LibreNew
88 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2022-03-14
© 2022 Business Of Biotech
L’épisode le plus récent
Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

Durée : 50:03
Lecture
This episode of the Business of Biotech is fire. In fact, it's an interview with SalioGen Therapeutics Chairman and CEO Ray Tabibiazar, M.D., whose last name literally translates to "Dr. Fire."  Learn how he got that name, what's shaped his technology-agnostic philosophy on therapeutic development,  the advantages of a genome engineering technology that leverages proprietary mammal-derived enzymes, rather than viruses, and how SalioGen is possibly carrying forth a pipeline that's 15 candidates deep and addressing eye, liver, heart, lung, bone marrow, and kidney diseases.
Learn more about gene therapy validation strategies at bioprocessonline.com.
Id. d’épisode : 1000553932076
GUID : Buzzsprout-10218273
Date de publication : 14/3/2022 à 11:00:00

Description

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.

Adresse du flux

https://feeds.buzzsprout.com/1011661.rss

Apple Podcasts : Avis des utilisateurs

Pas d'entrée